GROSSE POINTE, Mich., July 21, 2015 /PRNewswire/ -- According to a 2014 survey conducted by the American Society for Dermatologic Surgery (ASDS), 68% of people said they're bothered by submental fullness or "double chin."
Dr. David Balle has been chosen as one of only three physicians in the State of Michigan to launch KYBELLA(TM) - The first and only FDA approved product to treat the appearance of submental fullness, or "double chin."
Dr. Balle has been chosen as one of only three physicians in the State of Michigan to launch this product and treat patients with this unique, first of its kind simple injectable medicine.
KYBELLA™ is the first and only FDA-approved injectable drug that contours and improves the appearance of submental fullness, or "double chin." Treatment with KYBELLA™ is a simple non-surgical 15-20 minute injectable in-office treatment and is customized to the patient's aesthetic goals for an improved chin profile. The results are permanent!
Dr. Balle is a board certified dermatologist in private practice at Grosse Pointe Dermatology. He received his medical degree from Wayne State University School of Medicine and was chief resident at Henry Ford Hospital in the Department of Dermatology. He specializes in cosmetic dermatology having a particular expertise in minimally invasive non-surgical facial rejuvenation. Dr. Balle is on the medical staff of St. John Hospital and Beaumont Hospital Grosse Pointe. Recently named a "Top Doc" in the HOUR Detroit Magazine, Dr. Balle not only uses his advanced expertise for his patients, he also teaches and trains Physicians nationwide in the proper and safest injection techniques to achieve optimal results for injectables and fillers. To learn more visit www.drballe.com, or call us at 313.886.2600.
Contact: David Balle Tel. 313.886.2600Email: [email protected]
RSS